To view the PDF file, sign up for a MySharenet subscription.

LIFE HEALTHCARE GROUP HOLDINGS LIMITED - Dealings in securities by a director and the company secretary and by directors of a major subsidiary

Release Date: 03/02/2017 16:57
Code(s): LHC     PDF:  
Wrap Text
Dealings in securities by a director and the company secretary and by directors of a major subsidiary

LIFE HEALTHCARE GROUP HOLDINGS LIMITED
(Incorporated in the Republic of South Africa)
(Registration number: 2003/002733/06)
ISIN: ZAE000145892
Share Code: LHC
(“Life Healthcare” or “the Company”)

DEALINGS IN SECURITIES BY A DIRECTOR AND THE COMPANY SECRETARY AND BY
DIRECTORS OF A MAJOR SUBSIDIARY

In compliance with the JSE Limited Listings Requirements, the following information is
disclosed:

Director                                   :     Petrus Phillippus van der Westhuizen
Company                                    :     Life Healthcare Group Holdings Limited
Nature of transaction                      :     Off-market vesting in terms of the Life Healthcare
                                                 2011 and 2012 Long Term Incentive Plan (LTIP)*
                                                 and on-market disposal of a portion of the
                                                 Company matched shares to cover the income tax
                                                 and costs of the transaction
Date of transaction                        :     2 February 2017
Number of securities                       :     10 469
Class of securities                        :     Ordinary shares
Selling price                              :     R33.9491
Highest price                              :     R34.35
Lowest price                               :     R33.65
Total value of transaction                 :     R355 413.13
Nature of interest                         :     Direct beneficial
Clearance obtained                         :     Yes

Company Secretary                          :     Fazila Patel
Company                                    :     Life Healthcare Group Holdings Limited
Nature of transaction                      :     Off-market vesting in terms of the Life Healthcare
                                                 2011 and 2012 Long Term Incentive Plan (LTIP)*
                                                 and on-market disposal of a portion of the
                                                 company matched shares to cover the income tax
                                                 and costs of the transaction
Date of transaction                        :     2 February 2017
Number of securities                       :     12 707
Class of securities                        :     Ordinary shares
Selling price                              :     R33.9491
Highest price                              :     R34.35
Lowest price                               :     R33.65
Total value of transaction                 :     R431 391.21
Nature of interest                         :     Direct beneficial
Clearance obtained                         :     Yes

Director                                   :     Christoffel Lourens Welthagen Bekker
Company                                    :     Life Healthcare Group (Proprietary) Limited (a
                                                 major subsidiary of the Company)
Nature of transaction                      :     Off-market vesting of shares in terms of the Life
                                                 Healthcare 2011 and 2012 Long Term Incentive
                                                 Plan (LTIP) and on-market disposal of the shares to
                                                 cover the income tax and costs of the transaction
                                                 as well as to fund his intended participation in the
                                                 proposed rights offer.
                                                 The director exercised his election to purchase:
                                                 10 453 Life Healthcare shares on-market at
                                                 R38.7219 per share in terms of the LTIP in January
                                                 2014 and 7 309 shares at R42.6397 per share in
                                                 2015 and was awarded 17 422 matched shares
                                                 which was purchased by the company in 2014 and
                                                 12 182 shares in 2015. These shares were
                                                 restricted for three and two years respectively.
Number of shares vesting and sold          :     47 366
Vesting date                               :     31 January 2017
Date of transaction                        :     2 February 2017
Class of securities                        :     Ordinary shares
Selling price                              :     R33.9491
Highest price                              :     R34.35
Lowest price                               :     R33.65
Total value of transaction                 :     R1 608 033.07
Nature of interest                         :     Direct beneficial
Clearance obtained                         :     Yes


Director                                   :     Kurt Aston Wylie
Company                                    :     Life Healthcare Group (Proprietary) Limited (a
                                                 major subsidiary of the Company)
Nature of transaction                      :     Off-market vesting of shares in terms of the Life
                                                 Healthcare 2011 and 2012 Long Term Incentive
                                                 Plan (LTIP) and on-market disposal of the shares to
                                                 cover the income tax and costs of the transaction
                                                 as well as to fund his intended participation in the
                                                 proposed rights offer.
                                                 The director exercised his election to purchase:
                                                 5 163 Life Healthcare shares on-market at
                                                 R38.7219 per share in terms of the LTIP in January
                                                 2014 and 4 476 shares at R42.6397 per share in
                                                 2015 and was awarded 8 605 matched shares
                                                 which was purchased by the company in 2014 and
                                                 7 459 shares in 2015. These shares were restricted
                                                 for three and two years respectively.
Number of shares vesting and sold          :     25 703
Vesting Date                               :     31 January 2017
Date of transaction                        :     2 February 2017
Class of securities                        :     Ordinary shares
Selling price                              :     R33.9491
Highest price                              :     R34.35
Lowest price                               :     R33.65
Total value of transaction                 :     R872 593.72
Nature of interest                         :     Direct beneficial
Clearance obtained                         :     Yes

Director                                   :     Pieter Francois Theron
Company                                    :     Life Healthcare Group (Proprietary) Limited (a
                                                 major subsidiary of the Company)
Nature of transaction                      :     Off-market vesting of shares in terms of the Life
                                                 Healthcare 2011 and 2012 Long Term Incentive
                                                 Plan (LTIP) and on-market disposal of the shares to
                                                 cover the income tax and costs of the transaction
                                                 as well as to fund his intended participation in the
                                                 proposed rights offer.
                                                 The director exercised his election to purchase:
                                                 7 152 Life Healthcare shares on-market at
                                                 R38.7219 per share in terms of the LTIP in January
                                                 2014 and 6 005 shares at R42.6397 per share in
                                                 2015 and was awarded 11 921 matched shares
                                                 which was purchased by the company in 2014 and
                                                 10 008 shares in 2015. These shares were
                                                 restricted for three and two years respectively.
Number of shares vesting and sold          :     35 086
Vesting date                               :     31 January 2017
Date of transaction                        :     2 February 2017
Class of securities                        :     Ordinary shares
Selling price                              :     R33.9491
Highest price                              :     R34.35
Lowest price                               :     R33.65
Total value of transaction                 :     R1 191 138.12
Nature of interest                         :     Direct beneficial
Clearance obtained                         :     Yes

*Shareholders are referred to the SENS announcements published on 30 January 2014 and 30 January 2015 where shareholders were advised that
the chief financial officer and the company secretary had purchased a number of Life Healthcare shares on-market in terms of the LTIP.


Illovo
3 February 2017

Sponsor
RAND MERCHANT BANK (A division of FirstRand Bank Limited)

Date: 03/02/2017 04:57:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.

Share This Story